Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly

Publisher： Karger

E-ISSN： 1663-2699|5|3|318-324

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.5, Iss.3, 2014-10, pp. : 318-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rescue Intravitreal Bevacizumab (Avastin) for Aggressive Posterior Retinopathy of Prematurity

By Qureshi Farhan   Dewhurst Christopher   Yoxall C.W.   Clark David  

Seminars in Ophthalmology, Vol. 26, Iss. 2, 2011-03 ,pp. : 55-58

Informa Healthcare

Access to resources Recommend Favorite

Effect of Single Intravitreal Bevacizumab on Ophthalmic and Middle Cerebral Arterial Blood Flow in Retinopathy of Prematurity

By  

Ophthalmic Research, Vol. 55, Iss. 4, 2016-01 ,pp. : 165-171

Karger

Access to resources Recommend Favorite

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-03 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity

By  

Ophthalmic Research, Vol. 53, Iss. 1, 2014-11 ,pp. : 15-20

Karger

Access to resources Recommend Favorite

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy

By  

Case Reports in Ophthalmology, Vol. 2, Iss. 3, 2011-09 ,pp. : 314-318

Karger

Access to resources Recommend Favorite